Search Results

You are looking at 1 - 3 of 3 items for

  • Author or Editor: Yu-Rong Chen x
  • Refine by Access: All Content x
Clear All Modify Search

Abstract  

A study on the synergistic extraction of uranium(VI) from nitric acid media with double-chelating agent systems 1-phenyl-3-methyl-4-benzoyl-pyrazolone-5 (PMBP) plus thenoyltrifluoroacetone (TTA), and 1-phenyl-3-methyl-4-benzoyl-pyrazolone-5 plus 1-phenyl-3-methyl-4-trifluoroacetyl-pyrazolone-5 (PMTFP) is described. Some synergistic effects have been observed. The experimental results suggest that the composition of synergistic complex species is UO2PMBP·TTA and UO2PMBP·PMTFP, respectively. The equilibrium constants for these synergistic extractions are calculated by three methods and the mechanism and the regularity of extraction are discussed as well.

Restricted access
Journal of Radioanalytical and Nuclear Chemistry
Authors: Yong He, Rui Ding, Hang Liu, Xiao Wang, Jing-Li Xu, Man Feng, Yu-Rong Chen, Chuan-Min Qi, Cheng Peng, Zhao-Hui Zhu, Yong-Hong Dang, Ming Wang, and Yun-Chuan Ma

Abstract  

As degradation product of Antineoplaston A10 in vivo, phenylacetyl glutamine showed antitumor activities. According to literatures, we designed and radiosynthesized a phenylacetyl glutamine derivative, which was achieved under a mild reaction condition. Evaluations in vitro and in vivo were performed on tumor bearing mice. Excitingly, the radiochemical purity of (S)-2-((S)-2-(4-(3-fluoropropyl)benzamido)-3-phenylpropanamido)pentanedioic acid ([18F]FBPPA) was 98%, and besides the best radiochemical yield was up to 46%. T/Bl (Tumor/Blood) and T/M (Tumor/Muscle) ratios of [18F]FBPPA at 60 min post injection were 2.33 and 3.51. Meanwhile, it showed satisfied stability in vitro and in vivo, compared with 2-[18F]fluorodeoxyglucose ([18F]FDG). Although [18F]FBPPA deserved further studies to make optimizations on its structure, the results revealed it might become a potential PET imaging agent for detecting tumors.

Restricted access
Journal of Radioanalytical and Nuclear Chemistry
Authors: Chuan-Min Qi, Yong He, Xiao Wang, Man Feng, Jing-Li Xu, Rui Ding, Hang Liu, Yu-Rong Chen, Fang Li, Zhao-Hui Zhu, Yong-Hong Dang, Shu-Ting Zhang, and Ying Xie

Abstract  

d-glucosamine at concentration of certain range could kill tumor cells without influencing normal cells. There are also some reports on the antitumor activity of d-glucosamine and its derivatives in murine models. It was therefore postulated that d-glucosamine might have the potential to invade tumor cells. We designed and radiosynthesized a glucosamine derivative, N-(2-[18F]fluoro-4-nitrobenzoyl)glucosamine ([18F]FNBG([18F]7)). Evaluations in vitro and in vivo were performed on tumor bearing mice. Excitingly, the radiochemical purity of [18F]FNBG([18F]7) was 99%, and besides the best radiochemical yield was up to 35%. The best T/Bl (Tumor/Blood) and T/M (Tumor/Muscle) ratios of [18F]FNBG([18F]7) were 4.40 and 4.84. Although [18F]FNBG([18F]7) deserved further studies, the results revealed it might become a potential PET imaging agent for detecting tumors.

Restricted access